BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32402360)

  • 1. Management of Oligometastatic Disease in Advanced Non-Small Cell Lung Cancer.
    West H
    Clin Chest Med; 2020 Jun; 41(2):249-258. PubMed ID: 32402360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligometastatic Disease (OMD): The Classification and Practical Review of Prospective Trials.
    Izmailov T; Ryzhkin S; Borshchev G; Boichuk S
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local control strategies for management of NSCLC with oligoprogressive disease.
    Mavrikios A; Remon J; Quevrin C; Mercier O; Tselikas L; Botticella A; Nicolas E; Deutsch E; Besse B; Planchard D; Barlesi F; Le Péchoux C; Levy A
    Cancer Treat Rev; 2023 Nov; 120():102621. PubMed ID: 37690180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is it too early to recommend local treatment in oligometastatic non-small cell lung cancer: a plea for equipoise.
    Ahmad I; Chufal KS; Miller AA; Bajpai R; Umesh P; Dawer A; Tandon S; Gandhidasan S; Dua B; Bhatia K; Gairola M
    Br J Radiol; 2024 May; 97(1157):913-919. PubMed ID: 38538948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measured Steps: Navigating the Path of Oligoprogressive Lung Cancer with Targeted and Immunotherapies.
    Jongbloed M; Khosla AA; Bartolomeo V; Jatwani K; Singh R; De Ruysscher DKM; Hendriks LEL; Desai A
    Curr Oncol Rep; 2024 Jan; 26(1):80-89. PubMed ID: 38175464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal treatment of oligometastatic non-small cell lung cancer.
    Graça LL; Pego A; Lareiro S; Pancas R
    BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38061851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining oligometastatic pancreatic cancer: a systematic review and critical synthesis of consensus.
    Leonhardt CS; Stamm T; Hank T; Prager G; Strobel O
    ESMO Open; 2023 Dec; 8(6):102067. PubMed ID: 37988953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local Ablative Therapies in Oligometastatic NSCLC: New Data and New Directions.
    Lang P; Gomez DR; Palma DA
    Semin Respir Crit Care Med; 2020 Jun; 41(3):369-376. PubMed ID: 32450591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial.
    Lieverse RIY; Van Limbergen EJ; Oberije CJG; Troost EGC; Hadrup SR; Dingemans AC; Hendriks LEL; Eckert F; Hiley C; Dooms C; Lievens Y; de Jong MC; Bussink J; Geets X; Valentini V; Elia G; Neri D; Billiet C; Abdollahi A; Pasquier D; Boisselier P; Yaromina A; De Ruysscher D; Dubois LJ; Lambin P
    BMC Cancer; 2020 Jun; 20(1):557. PubMed ID: 32539805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery for Locally Advanced and Oligometastatic Non-Small Cell Lung Cancer.
    Coster JN; Groth SS
    Surg Oncol Clin N Am; 2020 Oct; 29(4):543-554. PubMed ID: 32883457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Reported Outcomes in the Era of Immunotherapy Trials.
    Gadgeel SM
    J Thorac Oncol; 2021 Apr; 16(4):516-518. PubMed ID: 33781441
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimal P2Y12 inhibition in older adults with acute coronary syndromes: a network meta-analysis of randomized controlled trials.
    Montalto C; Morici N; Munafò AR; Mangieri A; Mandurino-Mirizzi A; D'Ascenzo F; Oreglia J; Latib A; Porto I; Colombo A; Savonitto S; De Servi S; Crimi G
    Eur Heart J Cardiovasc Pharmacother; 2022 Jan; 8(1):20-27. PubMed ID: 32835355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding Iatrogenic Atrial Septal Defects: Moving in the "Right" Direction.
    Latib A; Rahgozar K
    JACC Cardiovasc Interv; 2020 Jul; 13(13):1554-1556. PubMed ID: 32646696
    [No Abstract]   [Full Text] [Related]  

  • 14. Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO-Friends of Cancer Research Joint Research Statement.
    Kim ES; Uldrick TS; Schenkel C; Bruinooge SS; Harvey RD; Magnuson A; Spira A; Wade JL; Stewart MD; Vega DM; Beaver JA; Denicoff AM; Ison G; Ivy SP; George S; Perez RP; Spears PA; Tap WD; Schilsky RL
    Clin Cancer Res; 2021 May; 27(9):2394-2399. PubMed ID: 33563632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Efficiency: Who's Got the Power?
    Yakubov SJ; Basuray A; Sanchez CS
    Cardiovasc Revasc Med; 2020 Nov; 21(11):1334-1335. PubMed ID: 32859537
    [No Abstract]   [Full Text] [Related]  

  • 16. Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study.
    Mok T; Camidge DR; Gadgeel SM; Rosell R; Dziadziuszko R; Kim DW; Pérol M; Ou SI; Ahn JS; Shaw AT; Bordogna W; Smoljanović V; Hilton M; Ruf T; Noé J; Peters S
    Ann Oncol; 2020 Aug; 31(8):1056-1064. PubMed ID: 32418886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The deleterious impact of a non-synonymous SNP on protein structure and function is apparent in hypertension.
    Sharma K; Hema K; Bhatraju NK; Kukreti R; Das RS; Gupta MD; Syed MA; Pasha MAQ
    J Mol Model; 2021 Dec; 28(1):14. PubMed ID: 34961886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical dermatologists on social media: a call to action.
    Sun HY; Sebaratnam DF
    J Am Acad Dermatol; 2021 Mar; 84(3):e163-e164. PubMed ID: 33470204
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
    Qin A; Zhao S; Miah A; Wei L; Patel S; Johns A; Grogan M; Bertino EM; He K; Shields PG; Kalemkerian GP; Gadgeel SM; Ramnath N; Schneider BJ; Hassan KA; Szerlip N; Chopra Z; Journey S; Waninger J; Spakowicz D; Carbone DP; Presley CJ; Otterson GA; Green MD; Owen DH
    J Natl Compr Canc Netw; 2021 Apr; 19(8):915-921. PubMed ID: 33878726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review.
    Kenner B; Chari ST; Kelsen D; Klimstra DS; Pandol SJ; Rosenthal M; Rustgi AK; Taylor JA; Yala A; Abul-Husn N; Andersen DK; Bernstein D; Brunak S; Canto MI; Eldar YC; Fishman EK; Fleshman J; Go VLW; Holt JM; Field B; Goldberg A; Hoos W; Iacobuzio-Donahue C; Li D; Lidgard G; Maitra A; Matrisian LM; Poblete S; Rothschild L; Sander C; Schwartz LH; Shalit U; Srivastava S; Wolpin B
    Pancreas; 2021 Mar; 50(3):251-279. PubMed ID: 33835956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.